About Jaguar Gene Therapy

What does Jaguar Gene Therapy do?

Jaguar Gene Therapy is a provider of AAV-based gene therapy candidates for severe genetic diseases, including JAG101, a preclinical therapy delivering the functional GALT gene via AAV9 for Type 1 galactosemia; JAG201, an investigational therapy targeting SHANK3-related disorders such as autism spectrum disorder and Phelan-McDermid syndrome; and JAG301, a preclinical therapy producing functional beta cells through transdifferentiation for Type 1 diabetes.

Who are Jaguar Gene Therapy's competitors?

Jaguar Gene Therapy's competitors and similar companies include Reapplix, Perceive Bio, Biochemical Systems, Poxel, and Ypsomed.

Where is Jaguar Gene Therapy headquartered?

Jaguar Gene Therapy is headquartered in United States.

How many employees does Jaguar Gene Therapy have?

Jaguar Gene Therapy has 1,000 employees 🔒.

When was Jaguar Gene Therapy founded?

Jaguar Gene Therapy was founded in 2010 🔒.

What sector and industry vertical is Jaguar Gene Therapy in?

Jaguar Gene Therapy is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Jaguar Gene Therapy

Who are the top strategic acquirers in Jaguar Gene Therapy's sector and industry

Top strategic M&A buyers and acquirers in Jaguar Gene Therapy's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Jaguar Gene Therapy?

Top strategic M&A buyers groups and sectors for Jaguar Gene Therapy include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Jaguar Gene Therapy's sector and industry vertical

Which are the top PE firms investing in Jaguar Gene Therapy's sector and industry vertical?

Top PE firms investing in Jaguar Gene Therapy's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Jaguar Gene Therapy's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Jaguar Gene Therapy's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Jaguar Gene Therapy's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Jaguar Gene Therapy include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Jaguar Gene Therapy's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Jaguar Gene Therapy?

The key public trading comparables and valuation benchmarks for Jaguar Gene Therapy include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Jaguar Gene Therapy for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Jaguar Gene Therapy with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Jaguar Gene Therapy's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Jaguar Gene Therapy with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Jaguar Gene Therapy's' sector and industry vertical?

Access recent funding rounds and capital raises in Jaguar Gene Therapy's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.